OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Adverse drug reactions and their fatal outcomes in clozapine patients in VigiBase: Comparing the top four reporting countries (US, UK, Canada and Australia)
Carlos De las Cuevas, Emílio J. Sanz, José de León
Schizophrenia Research (2023)
Open Access | Times Cited: 16
Carlos De las Cuevas, Emílio J. Sanz, José de León
Schizophrenia Research (2023)
Open Access | Times Cited: 16
Showing 16 citing articles:
When, Why and How to Re-challenge Clozapine in Schizophrenia Following Myocarditis
Mishal Qubad, Gabriele Dupont, Martina Hahn, et al.
CNS Drugs (2024) Vol. 38, Iss. 9, pp. 671-696
Open Access | Times Cited: 4
Mishal Qubad, Gabriele Dupont, Martina Hahn, et al.
CNS Drugs (2024) Vol. 38, Iss. 9, pp. 671-696
Open Access | Times Cited: 4
Clozapine Induces Agranulocytosis via Inflammatory and Hematopoietic Cytokine Induction of the JAK–STAT Signaling Pathway: Evidence From Network Pharmacology and Molecular Docking
Ying Zhang, Ranli Li, Ximing Chen, et al.
CNS Neuroscience & Therapeutics (2025) Vol. 31, Iss. 1
Open Access
Ying Zhang, Ranli Li, Ximing Chen, et al.
CNS Neuroscience & Therapeutics (2025) Vol. 31, Iss. 1
Open Access
Clozapine pharmacovigilance in Croatia: underreporting of specific adverse drug reactions and excellent reporting of suicide attempts
José de León, Marina Šagud, Emílio J. Sanz, et al.
Psychiatry Research (2025), pp. 116408-116408
Closed Access
José de León, Marina Šagud, Emílio J. Sanz, et al.
Psychiatry Research (2025), pp. 116408-116408
Closed Access
An expert review of clozapine in Eastern European countries: Use, regulations and pharmacovigilance
Marina Šagud, Dagmar Breznoščáková, Andreja Čelofiga, et al.
Schizophrenia Research (2023) Vol. 268, pp. 53-59
Closed Access | Times Cited: 12
Marina Šagud, Dagmar Breznoščáková, Andreja Čelofiga, et al.
Schizophrenia Research (2023) Vol. 268, pp. 53-59
Closed Access | Times Cited: 12
An expert review of clozapine in Latin American countries: Use, monitoring, and pharmacovigilance
Trino Baptista, Mariano Motuca, Ana Serrano, et al.
Schizophrenia Research (2023)
Closed Access | Times Cited: 9
Trino Baptista, Mariano Motuca, Ana Serrano, et al.
Schizophrenia Research (2023)
Closed Access | Times Cited: 9
Promoting safer and wider worldwide use of clozapine
José de León
Schizophrenia Research (2024)
Closed Access | Times Cited: 3
José de León
Schizophrenia Research (2024)
Closed Access | Times Cited: 3
A Pharmacovigilance Study on Clozapine in the Food and Drug Administration Adverse Event Reporting System: A Regional Comparative Analysis
Masakazu Hatano, Haruna Araki, Takeo Saito, et al.
Clinical Psychopharmacology and Neuroscience (2024) Vol. 22, Iss. 3, pp. 442-450
Open Access | Times Cited: 3
Masakazu Hatano, Haruna Araki, Takeo Saito, et al.
Clinical Psychopharmacology and Neuroscience (2024) Vol. 22, Iss. 3, pp. 442-450
Open Access | Times Cited: 3
Investigating in VigiBase® over 6000 cases of pneumonia in clozapine-treated patients in the context of the literature: focus on high lethality and the association with aspiration pneumonia
José de León, Can‐Jun Ruan, Georgios Schoretsanitis, et al.
Expert Opinion on Drug Metabolism & Toxicology (2024) Vol. 20, Iss. 8, pp. 857-871
Closed Access | Times Cited: 3
José de León, Can‐Jun Ruan, Georgios Schoretsanitis, et al.
Expert Opinion on Drug Metabolism & Toxicology (2024) Vol. 20, Iss. 8, pp. 857-871
Closed Access | Times Cited: 3
Clozapine may consistently protect from suicidal behaviors while other antipsychotics may lack a specific protective effect: a comprehensive VigiBase study interpreted in the context of the prior literature
Carlos De las Cuevas, Victoria de León-Martínez, Hilario Blasco‐Fontecilla, et al.
Expert Opinion on Drug Safety (2024), pp. 1-11
Closed Access | Times Cited: 3
Carlos De las Cuevas, Victoria de León-Martínez, Hilario Blasco‐Fontecilla, et al.
Expert Opinion on Drug Safety (2024), pp. 1-11
Closed Access | Times Cited: 3
Comprehensive dissection of prevalence rates, sex differences, and blood level-dependencies of clozapine-associated adverse drug reactions
Marte Z. van der Horst, Yoeki Meijer, Nini de Boer, et al.
Psychiatry Research (2023) Vol. 330, pp. 115539-115539
Open Access | Times Cited: 7
Marte Z. van der Horst, Yoeki Meijer, Nini de Boer, et al.
Psychiatry Research (2023) Vol. 330, pp. 115539-115539
Open Access | Times Cited: 7
Pharmacovigilance in Action: Utilizing VigiBase Data to Improve Clozapine Safety
Carlos De las Cuevas, Emílio J. Sanz, José de León
Patient Preference and Adherence (2024) Vol. Volume 18, pp. 2261-2280
Open Access | Times Cited: 2
Carlos De las Cuevas, Emílio J. Sanz, José de León
Patient Preference and Adherence (2024) Vol. Volume 18, pp. 2261-2280
Open Access | Times Cited: 2
Prevalence and predictors of QTc prolongation in patients seen in a clozapine clinic in a real-world setting in Australia
Anoop Sankaranarayanan, Sharmin Kazi, Chittaranjan Andrade
Schizophrenia Research (2023) Vol. 268, pp. 145-149
Closed Access | Times Cited: 6
Anoop Sankaranarayanan, Sharmin Kazi, Chittaranjan Andrade
Schizophrenia Research (2023) Vol. 268, pp. 145-149
Closed Access | Times Cited: 6
Clozapine safety monitoring and related research in psychiatry and neurology in South America: A scoping review
Trino Baptista, Ana Serrano, Alirio Pérez Lo Presti, et al.
Schizophrenia Research (2023)
Closed Access | Times Cited: 4
Trino Baptista, Ana Serrano, Alirio Pérez Lo Presti, et al.
Schizophrenia Research (2023)
Closed Access | Times Cited: 4
Group arts therapies for patients with schizophrenia: a protocol of systematic review and meta-analysis
Aijia Zhang, Xuexing Luo, Runqing Lin, et al.
BMJ Open (2024) Vol. 14, Iss. 6, pp. e082076-e082076
Open Access
Aijia Zhang, Xuexing Luo, Runqing Lin, et al.
BMJ Open (2024) Vol. 14, Iss. 6, pp. e082076-e082076
Open Access
The introduction of clozapine at the Nathan Kline Institute in New York and its long-term consequences
José de León, Linda Wang, George M. Simpson
Schizophrenia Research (2023) Vol. 268, pp. 14-20
Closed Access | Times Cited: 1
José de León, Linda Wang, George M. Simpson
Schizophrenia Research (2023) Vol. 268, pp. 14-20
Closed Access | Times Cited: 1
Current practice for clozapine-induced leukopenia in Japanese psychiatric hospitals: A nationwide survey
Tomihisa Niitsu, Norio Yasui‐Furukori, Ken Inada, et al.
Schizophrenia Research (2023) Vol. 268, pp. 82-87
Closed Access | Times Cited: 1
Tomihisa Niitsu, Norio Yasui‐Furukori, Ken Inada, et al.
Schizophrenia Research (2023) Vol. 268, pp. 82-87
Closed Access | Times Cited: 1
